Expertise in
3
conditions

Dr. Gad Kletter

Pediatric Endocrinology
MultiCare Health System
311 S L St, 
Tacoma, WA 
Referral may be required
Expertise in
3
conditions
MultiCare Health System
311 S L St, 
Tacoma, WA 

Overview

Gad Kletter is a Pediatric Endocrinologist practicing medicine in Tacoma, Washington.

Dr. Kletter is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Precocious Puberty, Pediatric Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), and Type 1 Diabetes (T1D).

He is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 4 clinical trials.

Specialties

Pediatric Endocrinology

Licenses

Pediatrics in WA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Community Health
  • EPO
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D

Locations

MultiCare Health System
311 S L St, Tacoma, WA 98405

Additional Areas of Focus

Dr. Kletter has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
Enrollment Status: Completed
Publish Date: July 20, 2025
Intervention Type: Drug
Study Drugs: MOD-4023, Somatropin
Study Phase: Phase 3
A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Drug
Study Drugs: LUM-201, rhGH Norditropin® pen
Study Phase: Phase 2
Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)
Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)
Enrollment Status: Completed
Publish Date: July 26, 2022
Intervention Type: Drug
Study Drug: Intranasal carbetocin
Study Phase: Phase 3
An Open-label, Single Arm, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Leuprolide Acetate 45 mg for Injectable Suspension Controlled Release in Subjects With Central (Gonadotropin-Dependent) Precocious Puberty
An Open-label, Single Arm, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Leuprolide Acetate 45 mg for Injectable Suspension Controlled Release in Subjects With Central (Gonadotropin-Dependent) Precocious Puberty
Enrollment Status: Completed
Publish Date: June 02, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

6 Total Publications

Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty.
Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 18, 2020
Similar Doctors
Expertise in
9
conditions
Dr. Christian Roth
Pediatric Endocrinology
Expertise in
9
conditions
Dr. Christian Roth
Pediatric Endocrinology

Seattle Children's Hospital

4800 Sand Point Way NE, 
Seattle, WA 
 (29.0 miles away)
206-987-2640
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Christian Roth is a Pediatric Endocrinologist practicing medicine in Seattle, Washington. Dr. Roth is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Obesity, Obesity in Children, Craniopharyngioma, and Congenital Hyperinsulinism.

Expertise in
8
conditions
Dr. Catherine Pihoker
Pediatric Endocrinology
Expertise in
8
conditions
Dr. Catherine Pihoker
Pediatric Endocrinology

Seattle Children's Hospital

4800 Sand Point Way NE, 
Seattle, WA 
 (29.0 miles away)
206-987-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Catherine Pihoker is a Pediatric Endocrinologist practicing medicine in Seattle, Washington. Dr. Pihoker is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Diabetic Ketoacidosis, and Maturity Onset Diabetes of the Young.

Expertise in
11
conditions
Dr. Patricia Fechner
Pediatric Endocrinology
Expertise in
11
conditions
Dr. Patricia Fechner
Pediatric Endocrinology

Seattle Children's Hospital

4800 Sand Point Way NE, 
Seattle, WA 
 (29.0 miles away)
206-987-2640
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Patricia Fechner is a Pediatric Endocrinologist practicing medicine in Seattle, Washington. Dr. Fechner is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Intersex, Congenital Adrenal Hyperplasia (CAH), Turner Syndrome, and Pediatric Growth Hormone Deficiency.

Frequently Asked Questions about Dr. Gad Kletter

How do I make an appointment with Dr. Gad Kletter?

You can book an appointment with Dr. Gad Kletter by calling their office at 253-792-6630. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Gad Kletter a top-rated expert for Precocious Puberty?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gad Kletter is classified as an Distinguished expert for Precocious Puberty, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Gad Kletter specialize in?

While Dr. Gad Kletter is a Pediatric Endocrinology, they have specific expertise in Precocious Puberty, Pediatric Growth Hormone Deficiency, and Growth Hormone Deficiency (GHD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Endocrinology.

Does Dr. Gad Kletter participate in research or clinical trials?

Yes. Dr. Gad Kletter has published 6 articles and abstracts on conditions like Precocious Puberty. You can view a list of Dr. Gad Kletter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Gad Kletter accept my insurance?

Dr. Gad Kletter accepts most major insurance plans, including Anthem BCBS and Community Health. We recommend calling the office directly at 253-792-6630 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kletter's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile